Current Hiv Research
Overview
Current HIV Research is a peer-reviewed journal that focuses on the latest advancements in HIV/AIDS research. It covers a wide range of topics, including virology, immunology, drug development, clinical trials, and public health interventions. The journal provides a platform for scientists, clinicians, and researchers to share their findings and contribute to the ongoing efforts in understanding, preventing, and treating HIV infection.
Details
Details
Abbr.
Curr HIV Res
Publisher
Bentham Science Publishers
Start
2003
End
Continuing
Frequency
Six issues per year, 2014-
p-ISSN
1570-162X
e-ISSN
1873-4251
Country
Netherlands
Language
English
Metrics
Metrics
h-index / Ranks: 6235
59
SJR / Ranks: 11845
301
CiteScore / Ranks: 10255
2.20
JIF / Ranks: 6819
1.0
Recent Articles
1.
Stamatatos L
Curr HIV Res
. 2025 Feb;
PMID: 39988778
An effective HIV-1 vaccine should elicit diverse immune responses, including broadly neutralizing antibodies (bNAbs). Such antibodies recognize regions of the viral envelope glyco-protein (Env) that are conserved among the diverse...
2.
Ariska V, Lubis N, Kembaren T
Curr HIV Res
. 2025 Feb;
PMID: 39957700
Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, often becomes a comorbidity in individuals infected with Human Immunodeficiency Virus (HIV), the cause of Acquired Immunodeficiency Syndrome (AIDS). HIV-positive individuals have a...
3.
Khazdooz H, Abbasian L, Shirzad N, Khashayar P, SeyedAlinaghi S, Malekahmadi M, et al.
Curr HIV Res
. 2025 Feb;
PMID: 39950464
Background: The increased risk of metabolic syndrome (MetS) and its subcomponents among people living with HIV/AIDS, especially in developing countries, is well documented with the global pooled prevalence of the...
4.
Li X, Zhu J, Fu L
Curr HIV Res
. 2025 Feb;
PMID: 39950463
Human Immunodeficiency Virus (HIV) remains a significant global health challenge, necessitating rapid, sensitive, and accessible diagnostic tools. We examined recent advancements in electrochemical sensors for HIV gene detection, focusing on...
5.
Kunwar A, N G, Khedkar V, Jha P
Curr HIV Res
. 2025 Feb;
PMID: 39945251
Introduction: The rapid increase in incidences of drug resistance and off-target toxicity in the case of Human Immunodeficiency Virus (HIV) has increased the demand for drugs with fewer side effects....
6.
Kuscu F, Yildirim F, Erturk D, Cabalak M, Komur S, Inal A, et al.
Curr HIV Res
. 2025 Feb;
PMID: 39945250
Background: About 10% of individuals with latent tuberculosis infection (LTBI) develop tuberculosis (TB) disease during their lifetime. People living with HIV (PLWH) have a significantly higher risk of developing tuberculosis...
7.
Sevimoglu T
Curr HIV Res
. 2025 Feb;
PMID: 39936446
Human Immunodeficiency Virus (HIV) damages or interferes with immune cell function and remains a serious worldwide public health concern. Many researchers have studied the virus since its discovery in an...
8.
Guan Y, Wang J, Lu X
Curr HIV Res
. 2025 Feb;
PMID: 39936445
Background: Circulating recombinant form (CRF) 01_AE and subtype C are two HIV-1 subtypes. In recent years, novel HIV-1 recombinant forms have become more and more prevalent in China; however, new...
9.
Maleki F, Farahmand M, Keyvani H
Curr HIV Res
. 2025 Jan;
PMID: 39844395
Aims: In people living with human immune deficiency (PLHIV), the rates of human papillomavirus (HPV) infection, mixed types, and high-risk (HR) strains increase, while the virus clearance is prevented. Here,...
10.
Geng K, Wei W, Chen S, Shi H, Fan W
Curr HIV Res
. 2024 Dec;
22(6):409-416.
PMID: 39648424
Objectives: The envelope glycoprotein (Env) on the surface of the human immunodeficiency virus (HIV-1) is a crucial protein that mediates binding to host cell receptors and subsequent membrane fusion. Env,...